Clinical Research Experience

Sr. No. Indication Phase of Trial No. Of patient enrolled Duration of enrolment Electronic data capture (EDC) Sponsor Status
1 MBC II 26 6 Months Yes Intas Pharmaceuticals, India Completed
2 MBC I 09 6 Months Yes Intas Pharmaceuticals, India Completed
3 MBC II 24 6 Months Yes Intas Pharmaceuticals, India Completed
4 MBC / MCC/Duke's C I (PK) [BA/BE] 17 3 Months Yes Intas Pharmaceuticals, India Completed
5 MBC / MCC/Duke's C I (PK) [BA/BE] 09 3 Months No Dr. Reddy’s Laboratories, India Completed
6 MBC / MCC/Duke's C I (PK) [BA/BE] 21 3 Months No Dr. Reddy’s Laboratories, India Completed
7 MBC / MCC/Duke's C I (PK) [BA/BE] 28 3 Months Yes Intas Pharmaceuticals, India Completed
8 MBC / MCC/Duke's C I (PK) [BA/BE] 09 3 Months No Hetero Labs Ltd, India Completed
9 Small Cell Lung Cancer I (PK) [BA/BE] 02 2 Months No Banner pharmacaps, USA Completed
10 GBM/Anaplastic Astrocytoma I (PK) [BA/BE] 04 4 Months No Fresenius Kabi Oncology ltd, India Completed
11 Pancreatic / Overian Cancer I (PK) [BA/BE] 10 4 Months Yes Intas Pharmaceuticals, India Completed
12 GBM / Anaplastic Astrocytoma I (PK) [BA/BE] 02 2 Months No Fresenius Kabi Oncology ltd, India Ongoing
13 CML I (PK) [BA/BE] 06 2 Months No Onco Therapies Limited, India Completed
14 CML I (PK) [BA/BE] 16 4 Months No Onco Therapies Limited, India Ongoing